Ask AI
ProCE Banner Activity

CE

Applying Best Practices to Prevent Wrong Drug Errors Associated with Generic Names (Archive)

Video

Applying Best Practices to Prevent Wrong Drug Errors Associated with Generic Names

Pharmacists: maximum of 0.50 contact hours

Pharmacy Technicians: maximum of 0.50 contact hours

Nurses: maximum of 0.50 contact hours

Released: October 27, 2025

Expiration: October 27, 2027

Share

Acknowledgement

This activity is supported by an independent educational grant from Azurity Pharmaceuticals, Inc.

Provider Statement

This activity is jointly provided by Partners for Advancing Clinical Education (Partners) and the Institute for Safe Medication Practices (ISMP)

Target Audience

Pharmacists, Pharmacy Technicians, Nurses

Learning Objectives

  • Describe the safety challenges associated with wrong drug medication errors due to similarity in generic names

  • Examine the contributing factors that lead to wrong drug errors associated with similarity in generic drug names

  • List recommendations for healthcare organizations to prevent and catch errors associated with similar generic names

Disclosure

Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.

 

Rita K. Jew, faculty for this activity, has served as a consultant/advisor/speaker for TB Alliance and has publicly traded stocks: Biogen, Amerisource Bergen, Arrowhead, Pharmaceuticals, Gilead, Glaxo Smith Kline, Novavax, TeleDoc, VaxArt, Vikings Therapeutics

Kara Jensen, faculty for this activity, has no relevant financial relationships.

Format

Video

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and ISMP. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Pharmacist Continuing Education
Partners designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUS) of the Accreditation Council for Pharmacy Education. 
Universal Activity Number - JA4008073-9999-25-339-H05-P/T
Type of Activity: Knowledge

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.

Additional Information

Instructions for Credit

  1. There are no fees for participating in and receiving CE credit for this activity.
  2. During the period October 20, 2025 through October 20, 2026, participants must read the educational objectives and faculty disclosures and study the educational activity.
  3. If you wish to receive acknowledgment for completing this activity, please complete the evaluation.
  4. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
  5. Pharmacists/Technicians: Upon successfully completing the activity evaluation, your credit will be submitted to CPE Monitor. Please check your NABP account within thirty (30) days to make sure the credit has posted.

Estimated time to complete activity: 0.5 hours